Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Diabetic nephropathies
MeSH D003928 - diabetic nephropathies
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D007674:
Kidney diseases
12 Companies
1 Drug
$
Success rate
D048909:
Diabetes complications
6 Companies
3 Drugs
$
Success rate
D003928:
Diabetic nephropathies
92 Companies
28 Drugs
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
92
%
12/13
Phase 2
57
%
27/47
Phase 3
62
%
36/58
Approved:
17
Overall Success rate:
33%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AbbVie
Hydrochlorothiazide
,
Atrasentan
Allergan
Amlodipine besylate
,
Ramipril
,
Valsartan
AstraZeneca
Enalapril
,
Felodipine
,
Enalaprilat
,
Angiotensin ii
,
Gliclazide
,
Tozorakimab
,
Glyclazide
,
Sglt2
,
Farxiga
1
2
3
4
5
6
7
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use